“…Our results show that characterization of CAH mutations for prenatal diagnosis or carrier detection remains difficult because many mutations must be tested. Linked genetic markers, HLA, but also duplications and deletions of CYP2lP or C4 genes, as well as some polymorphisms on CYP21, may be used to follow the segregation of CAH alleles in families with an index case (Mornet et al, 1986b;Raux-Demay et al, 1989; and our unpublished results). More inclusive strategies such as DGGE or SSCP may lead to the characterization of most, but not all, of the mutations, as it seems that some mutations or polymorphisms may be undetected by these methodologies (FQec et al, 1992;Hayashi and Yandell, 1993).…”